林 懷正

研究成果

每年研究成果 1987 1988 1995 2008 2009 2012 2013 2021

• 155 文章
• 6 快報
• 1 書籍
• 1 回顧型文獻

每年研究成果

每年研究成果

搜尋結果

• Meperidine as the single sedative agent during esophagogastroduodenoscopy, a double-blind, randomized, controlled study

  Hsieh, Y. H., Lin, H. J., Hsieh, J. J., Tseng, K. C., Tseng, C. W., Hung, T. H. & Leung, F. W., 2013, 於: Journal of Gastroenterology and Hepatology (Australia). 28, 7, p. 1167-1173 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Digestive System Endoscopy 100%
  • Meperidine 96%
  • Hypnotics and Sedatives 75%
  • Intramuscular Injections 16%
  • Colonoscopy 15%
  4 引文 斯高帕斯（Scopus）

• Missed opportunities in the trial on proton-pump inhibitor therapy in bleeding peptic ulcers [3]

  Lin, H. J. & Hsu, Y. C., 10月 20 2009, 於: Annals of Internal Medicine. 151, 8, p. 589 1 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Mixed Infections of Helicobacter pylori Isolated from Patients with Gastrointestinal Diseases in Taiwan

  Lai, C. H., Huang, J. C., Chiang-Ni, C., Li, J. P., Wu, L. T., Wu, H. S., Sun, Y. C., Lin, M. L., Lee, J. F. & Lin, H. J., 2016, 於: Gastroenterology Research and Practice. 2016, 7521913.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Gastrointestinal Diseases 100%
  • Taiwan 92%
  • Coinfection 91%
  • Helicobacter pylori 91%
  • Helicobacter pylori VacA protein 29%
  12 引文 斯高帕斯（Scopus）

• Modulation of T cell response by Phellinus linteus

  Lin, C. J., Lien, H. M., Lin, H. J., Huang, C. L., Kao, M. C., Chen, Y. A., Wang, C. K., Chang, H. Y., Chang, Y. K., Wu, H. S. & Lai, C. H., 1月 1 2016, 於: Journal of Bioscience and Bioengineering. 121, 1, p. 84-88 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • T-cells 100%
  • Polysaccharides 73%
  • Polysaccharide 57%
  • Modulation 51%
  • T-Lymphocytes 41%
  10 引文 斯高帕斯（Scopus）

• Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis

  Hsu, Y. C., Yang, T. H., Hsu, W. L., Wu, H. T., Cheng, Y. C., Chiang, M. F., Wang, C. S. & Lin, H. J., 8月 2010, 於: British Journal of Clinical Pharmacology. 70, 2, p. 171-179 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • mosapride 100%
  • Lansoprazole 83%
  • Peptic Esophagitis 76%
  • Placebos 35%
  • Acids 6%
  25 引文 斯高帕斯（Scopus）

• Mucosal polymerase chain reaction for diagnosing Helicobacter pylori infection in patients with bleeding peptic ulcers

  Lin, H. J., Lo, W. C., Perng, C. L., Tseng, G. Y., Li, A. F. Y. & Ou, Y. H., 1月 21 2005, 於: World Journal of Gastroenterology. 11, 3, p. 382-385 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Peptic Ulcer 100%
  • Helicobacter Infections 99%
  • Helicobacter pylori 90%
  • Hemorrhage 60%
  • Gastritis 31%
  9 引文 斯高帕斯（Scopus）

• Mutagenicity study of butachlor and its metabolites using Salmonella typhimurium

  Hsu, K. Y., Lin, H. J., Lin, J. K., Kuo, W. S. & Ou, Y. H., 12月 2005, 於: Journal of Microbiology, Immunology and Infection. 38, 6, p. 409-416 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • butachlor 100%
  • Salmonella typhimurium 59%
  • Herbicides 8%
  • Mutagens 7%
  • Metabolic Networks and Pathways 6%
  9 引文 斯高帕斯（Scopus）

• Natural history of bleeding peptic ulcers with a tightly adherent blood clot: a prospective observation

  Lin, H. J., Wang, K., Perng, C. L., Lee, F. Y., Lee, C. H. & Lee, S. D., 1996, 於: Gastrointestinal Endoscopy. 43, 2 PART 2, p. 470-473 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Peptic Ulcer 100%
  • Thrombosis 72%
  • Observation 66%
  • Hemorrhage 60%
  • Odds Ratio 36%
  39 引文 斯高帕斯（Scopus）

• Non-variceal upper gastrointestinal bleeding and application of haemoclips

  Lin, H. J., 7月 2008, 於: Gut. 57, 7, p. 1023 1 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Octreotide and heater probe thermocoagulation for arrest of peptic ulcer hemorrhage: A prospective, randomized, controlled trial

  Lin, H. J., Wang, K., Perng, C. L., Chua, R. T., Lee, C. H. & Lee, S. D., 1995, 於: Journal of Clinical Gastroenterology. 21, 2, p. 95-98 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Peptic Ulcer Hemorrhage 100%
  • Electrocoagulation 70%
  • Octreotide 69%
  • Randomized Controlled Trials 38%
  • Peptic Ulcer 24%
  3 引文 斯高帕斯（Scopus）

• Octreotide for arrest of peptic ulcer hemorrhage - A prospective, randomized controlled trial

  Lin, H. J., Perng, C. L., Wang, K., Lee, C. H. & Lee, S. D., 1995, 於: Hepato-Gastroenterology. 42, 6, p. 856-860 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Peptic Ulcer Hemorrhage 100%
  • Octreotide 69%
  • Randomized Controlled Trials 38%
  • Ranitidine 24%
  • Endoscopic Hemostasis 14%
  25 引文 斯高帕斯（Scopus）

• Omeprazole plus amoxicillin versus triple therapy eradicates Helicobacter pylori in the Chinese with peptic ulcer disease

  Wang, K., Lin, H. J., Chua, R. T., Perng, C. L., Tsay, S. H. & Lee, S. D., 3月 1996, 於: Chinese Medical Journal (Taipei). 57, 3, p. 184-190 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Omeprazole 100%
  • Amoxicillin 91%
  • Peptic Ulcer 88%
  • Helicobacter pylori 79%
  • Group Psychotherapy 24%
  3 引文 斯高帕斯（Scopus）

• Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection

  Tsai, J. J., Hsu, Y. C., Perng, C. L. & Lin, H. J., 3月 2009, 於: British Journal of Clinical Pharmacology. 67, 3, p. 326-332 7 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Proton Pump Inhibitors 100%
  • Peptic Ulcer 95%
  • Epinephrine 82%
  • Hemorrhage 57%
  • Injections 51%
  22 引文 斯高帕斯（Scopus）

• Oral versus intravenous proton pump inhibitors in preventing re-bleeding for patients with peptic ulcer bleeding after successful endoscopic therapy

  Yen, H. H., Yang, C. W., Su, W. W., Soon, M. S., Wu, S. S. & Lin, H. J., 6月 8 2012, 於: BMC Gastroenterology. 12, 66.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  開啟存取

  • Proton Pump Inhibitors 100%
  • Peptic Ulcer 95%
  • Hemorrhage 57%
  • Length of Stay 54%
  • Esomeprazole 52%
  25 引文 斯高帕斯（Scopus）

• Pancreas divisum

  Malik, U., Lai, K. H., Lin, C. Y., Chang, F. Y., Lin, H. J., Lui, W. Y., Lee, S. D. & Tsai, Y. T., 1989, 於: Chinese Journal of Gastroenterology. 6, 1, p. 35-39 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease

  Tseng, G. Y. & Lin, H. J., 2010, 於: Gastrointestinal Endoscopy. 71, 7, p. 1333-1334 2 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Phase II study of mitoxantrone in unresectable primary hepatocellular carcinoma following hepatitis B infection

  Lai, K. H., Tsai, Y. T., Lee, S. D., Ng, W. W., Teng, H. C., Tam, T. N., Lo, G. H., Lin, H. C., Lin, H. J., Wu, J. C., Lay, C. S., Wang, S. S. & Chan, W. K., 1月 1989, 於: Cancer Chemotherapy and Pharmacology. 23, 1, p. 54-56 3 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Mitoxantrone 100%
  • Hepatitis B 65%
  • Hepatocellular Carcinoma 54%
  • Infections 32%
  • Antitumor 15%
  2 引文 斯高帕斯（Scopus）

• Poor Responders to Intravenous Omeprazole in Patients with Peptic Ulcer Bleeding

  Hsieh, Y. H., Lin, H. J., Tseng, G. Y., Perng, C. L., Wang, K., Lo, W. C., Chang, F. Y. & Lee, S. D., 1月 2004, 於: Hepato-Gastroenterology. 51, 55, p. 316-319 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Omeprazole 100%
  • Peptic Ulcer 88%
  • Hemorrhage 53%
  • Endoscopic Hemostasis 11%
  • Proton Pump Inhibitors 8%
  6 引文 斯高帕斯（Scopus）

• Predictive factors for rebleeding in patients with peptic ulcer bleeding after multipolar electrocoagulation: A retrospective analysis

  Lin, H. J., Tseng, G. Y., Lo, W. C., Lee, F. Y., Perng, C. L., Chang, F. Y. & Lee, S. D., 3月 1998, 於: Journal of Clinical Gastroenterology. 26, 2, p. 113-116 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Electrocoagulation 100%
  • Peptic Ulcer 86%
  • Hemorrhage 51%
  • Omeprazole 24%
  • Hemostasis 20%
  14 引文 斯高帕斯（Scopus）

• Prevalence of antimicrobial resistance in Helicobacter pylori isolates in Taiwan in relation to consumption of antimicrobial agents

  Poon, S. K., Lai, C. H., Chang, C. S., Lin, W. Y., Chang, Y. C., Wang, H. J., Lin, P. H., Lin, H. J. & Wang, W. C., 8月 2009, 於: International Journal of Antimicrobial Agents. 34, 2, p. 162-165 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Clarithromycin 100%
  • Lansoprazole 98%
  • Anti-Infective Agents 85%
  • Taiwan 82%
  • Helicobacter pylori 81%
  18 引文 斯高帕斯（Scopus）

• Prognostic factors in gastrointestinal bleeding due to peptic ulcer, construction of a predictive model

  Lin, H. J., 7月 2009, 於: Journal of Clinical Gastroenterology. 43, 6, p. 597 1 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Propofol alone versus propofol in combination with meperidine for sedation during colonoscopy.

  Hsieh, Y. H., Chou, A. L., Lai, Y. Y., Chen, B. S., Sia, S. L., Chen, I. C., Chang, Y. L. & Lin, H. J., 9月 2009, 於: Journal of Clinical Gastroenterology. 43, 8, p. 753-757 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Meperidine 100%
  • Propofol 82%
  • Colonoscopy 79%
  • Nurse Anesthetists 9%
  • Anesthetists 7%
  29 引文 斯高帕斯（Scopus）

• Proton pump inhibitors after endoscopy in peptic ulcer bleeding

  Lin, H. J., 6月 2009, 於: American Journal of Gastroenterology. 104, 6, p. 1595 1 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  2 引文 斯高帕斯（Scopus）

• Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: Is therapeutic response predicted by Rome III subgroups?

  Hsu, Y. C., Liou, J. M., Yang, T. H., Hsu, W. L., Lin, H. J., Wu, H. T., Lin, J. T., Wang, H. P. & Wu, M. S., 2月 2011, 於: Journal of Gastroenterology. 46, 2, p. 183-190 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Dyspepsia 100%
  • Proton Pump Inhibitors 97%
  • mosapride 54%
  • Lansoprazole 45%
  • Hong Kong 23%
  38 引文 斯高帕斯（Scopus）

• Pseudoachalasia From Gastric Cancer

  Hsu, Y. C., Li, A. F. Y. & Lin, H. J., 9月 2009, 於: Clinical Gastroenterology and Hepatology. 7, 9

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Pseudomelanosis duodeni: Case report and review of literature

  Lin, H. J., Tsay, S. H., Chiang, H., Tsai, Y. T., Lee, S. D., Yeh, Y. S. & Lo, G. H., 1988, 於: Journal of Clinical Gastroenterology. 10, 2, p. 155-159 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Lipofuscin 100%
  • Rare Diseases 72%
  • Electron Microscopy 63%
  • Iron 61%
  2 引文 斯高帕斯（Scopus）

• Pseudomelanosis duodeni: report of eight cases.

  Wang, K., Lin, H. J., Perng, C. L., Chiang, H., Lee, C. T., Chang, F. Y. & Lee, S. D., 10月 1995, 於: Journal of the Formosan Medical Association = Taiwan yi zhi. 94, 10, p. 632-634 3 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Iron 100%
  • Macrophages 56%
  • Lysosomes 40%
  • Duodenum 40%
  • Electron Microscopy 34%
  7 引文 斯高帕斯（Scopus）

• Psychopathology and personality trait in subgroups of functional dyspepsia based on Rome III criteria

  Hsu, Y. C., Liou, J. M., Liao, S. C., Yang, T. H., Wu, H. T., Hsu, W. L., Lin, H. J., Wang, H. P. & Wu, M. S., 10月 2009, 於: American Journal of Gastroenterology. 104, 10, p. 2534-2542 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Dyspepsia 100%
  • Psychopathology 85%
  • Personality 77%
  • Linear Models 22%
  • Pain 22%
  46 引文 斯高帕斯（Scopus）

• Recurrence of peptic ulcer in uraemic and non-uraemic patients after Helicobacter pylori eradication: A 2-year study

  Tseng, G. Y., Lin, H. J., Fang, C. T., Yang, H. B., Tseng, G. C., Wang, P. C., Hung, T. L., Deng, Y. C., Cheng, Y. T. & Huang, C. H., 9月 2007, 於: Alimentary Pharmacology and Therapeutics. 26, 6, p. 925-933 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Peptic Ulcer 100%
  • varespladib methyl 97%
  • Helicobacter pylori 90%
  • Recurrence 53%
  • Chronic Kidney Failure 41%
  27 引文 斯高帕斯（Scopus）

• Reply

  Lin, H. J., 2月 1991, 於: Gastroenterology. 100, 2, p. 576-577 2 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Response to Dr. Netzer and Inauen's comments [7]

  Lin, H. J., 12月 2006, 於: American Journal of Gastroenterology. 101, 12, p. 2889 1 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Response to Peng et al [8]

  Lin, H. J., 7月 2006, 於: Journal of Clinical Gastroenterology. 40, 6, p. 562-563 2 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Retrospective analysis of endoscopic management of foreign bodies in the upper gastrointestinal tract of adults

  Lee, C. Y., Kao, B. Z., Wu, C. S., Chen, M. Y., Chien, H. Y., Wu, L. W., Lin, S. T., Lai, Y. H. & Lin, H. J., 2月 1 2019, 於: Journal of the Chinese Medical Association : JCMA. 82, 2, p. 105-109 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Upper Gastrointestinal Tract 100%
  • Foreign Bodies 85%
  • Esophagus 18%
  • Hypopharynx 13%
  • Duodenum 10%
  15 引文 斯高帕斯（Scopus）

• Risk stratification by using an esophageal capsule

  Lin, H. J., 10月 2013, 於: Gastrointestinal Endoscopy. 78, 4, p. 672 1 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Role of intravenous omeprazole in patients with high-risk peptic ulcer bleeding after successful endoscopic epinephrine injection: A prospective randomized comparative trial

  Lin, H. J., Lo, W. C., Cheng, Y. C. & Perng, C. L., 3月 2006, 於: American Journal of Gastroenterology. 101, 3, p. 500-505 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Omeprazole 100%
  • Peptic Ulcer 88%
  • Epinephrine 76%
  • Cimetidine 65%
  • Hemorrhage 53%
  22 引文 斯高帕斯（Scopus）

• Scoring system in upper GI bleeding

  Lin, H. J., 9月 2013, 於: Gastrointestinal Endoscopy. 78, 3, p. 557 1 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Serum c-erbB-2 oncoprotein in the diagnosis of gastric cancer in comparison with CA 19-9, CEA, TPA, CA 125 and AFP.

  Perng, C. L., Lin, H. J. & Lee, S. D., 8月 1994, 於: Chinese Medical Journal (Taipei). 54, 2, p. 82-86 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Oncogene Proteins 100%
  • Stomach Neoplasms 77%
  • Tumor Biomarkers 54%
  • Serum 40%
  • Colonic Neoplasms 20%
  2 引文 斯高帕斯（Scopus）

• Simvastatin therapy for drug repositioning to reduce the risk of prostate cancer mortality in patients with hyperlipidemia

  Chen, Y. A., Lin, Y. J., Lin, C. L., Lin, H. J., Wu, H. S., Hsu, H. Y., Sun, Y. C., Wu, H. Y., Lai, C. H. & Kao, C. H., 3月 22 2018, 於: Frontiers in Pharmacology. 9, MAR, 225.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Drug Repositioning 100%
  • Simvastatin 86%
  • Hyperlipidemias 73%
  • Prostatic Neoplasms 57%
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors 56%
  23 引文 斯高帕斯（Scopus）

• Skeptical that pantoprazole dose can prevent bleeding

  Lin, H. J. & Tsai, J. J., 9月 2008, 於: American Journal of Critical Care. 17, 5, p. 404 1 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

• Statins attenuate helicobacter pylori CagA translocation and reduce incidence of gastric cancer: In Vitro and population-based case-control studies

  Lin, C. J., Liao, W. C., Lin, H. J., Hsu, Y. M., Lin, C. L., Chen, Y. A., Feng, C. L., Chen, C. J., Kao, M. C., Lai, C. H. & Kao, C. H., 1月 5 2016, 於: PLoS ONE. 11, 1, e0146432.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Cytotoxins 100%
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors 86%
  • Helicobacter pylori 86%
  • Stomach Neoplasms 77%
  • Case-Control Studies 71%
  43 引文 斯高帕斯（Scopus）

• Statin therapy is associated with reduced risk of peptic ulcer disease in the Taiwanese population

  Lin, C. J., Liao, W. C., Chen, Y. A., Lin, H. J., Feng, C. L., Lin, C. L., Lin, Y. J., Kao, M. C., Huang, M. Z., Lai, C. H. & Kao, C. H., 4月 28 2017, 於: Frontiers in Pharmacology. 8, APR, 210.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Peptic Ulcer 100%
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors 90%
  • Population 36%
  • Fluvastatin 16%
  • Pravastatin 15%
  13 引文 斯高帕斯（Scopus）

• Surgical results of early gastric cancer and proposing a treatment strategy

  Lo, S. S., Wu, C. W., Chen, J. H., Li, A. F. Y., Hsieh, M-C., Shen, K. H., Lin, H. J. & Lui, W. Y., 2月 2007, 於: Annals of Surgical Oncology. 14, 2, p. 340-347 8 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Stomach Neoplasms 100%
  • Lymph Nodes 45%
  • Recurrence 44%
  • Survival 42%
  • Neoplasms 28%
  48 引文 斯高帕斯（Scopus）

• Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells

  Chang, C. S., Liu, J. F., Lin, H. J., Lin, C. D., Tang, C. H., Lu, D. Y., Sing, Y. T., Chen, L. Y., Kao, M. C., Kuo, S. C. & Lai, C. H., 2月 2012, 於: European Journal of Medicinal Chemistry. 48, p. 244-252 9 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Benzimidazole 100%
  • Helicobacter pylori 93%
  • Stomach 69%
  • Epithelial Cells 68%
  • Antimicrobial Agent 67%
  17 引文 斯高帕斯（Scopus）

• The Cronkhite-Canada syndrome with focus on immunity and infection

  Lin, H. J., Tsai, Y. T., Lee, S. D., Lai, K. H., Ng, W. W., Tam, T. N., Lin, H. C., Liou, L. B. & Tsay, S. H., 1988, 於: Journal of Clinical Gastroenterology. 10, 5, p. 568-570 3 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Intestinal Polyposis 100%
  • Immunity 49%
  • Protein-Losing Enteropathies 45%
  • Skin Pigmentation 36%
  • Alopecia 32%
  1 引文 斯高帕斯（Scopus）

• The Cronkhite-Canada syndrome with focus on immunity and infection report of a case

  Lin, H. J., Tsai, Y. T., Lee, S. D., Lai, K. H., Ng, W. W., Tarn, T. N., Lin, H. C., Liou, L. B. & Tsay, S. H., 1987, 於: Journal of Clinical Gastroenterology. 9, 5, p. 568-570 3 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Intestinal Polyposis 100%
  • Immunity 49%
  • Protein-Losing Enteropathies 45%
  • Skin Pigmentation 36%
  • Alopecia 32%
  10 引文 斯高帕斯（Scopus）

• The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach

  Wang, K., Lin, H. J., Perng, C. L., Tseng, G. Y., Yu, K. W., Chang, F. Y. & Lee, S. D., 9月 2004, 於: Hepato-Gastroenterology. 51, 59, p. 1540-1543 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Histamine H2 Receptors 100%
  • Proton Pump Inhibitors 89%
  • Stomach 57%
  • Gastric Juice 29%
  • Bacterial Infections 21%
  36 引文 斯高帕斯（Scopus）

• The influence of intravenous omeprazole on intragastric pH and outcomes in patients with peptic ulcer bleeding after successful endoscopic therapy - A prospective randomized comparative trial

  Tseng, G. Y., Lin, H. J., Lin, H. Y., Perng, C. L., Lee, F. Y., Lo, W. C., Chang, F. Y. & Lee, S. D., 1999, 於: Hepato-Gastroenterology. 46, 28, p. 2183-2188 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Omeprazole 100%
  • Peptic Ulcer 88%
  • Hemorrhage 53%
  • Therapeutics 13%
  • Endoscopic Hemostasis 10%
  1 引文 斯高帕斯（Scopus）

• The influence of sham feeding on gastric acid and pepsin secretion in the Chinese with duodenal ulcer and liver cirrhosis.

  Lin, H. J., Perng, C. L. & Lee, S. D., 12月 1994, 於: Chinese Medical Journal (Taipei). 54, 6, p. 389-394 6 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Pepsin A 100%
  • Gastric Acid 94%
  • Duodenal Ulcer 89%
  • Liver Cirrhosis 74%
  • Acids 30%

• Therapeutic effects of low-dose acid-reducing agents in patients with duodenal ulcer

  Lai, K. H., Ng, W. W., Tsai, Y. T., Tam, T. N., Lo, G. H., Chang, F. Y., Lin, H. J. & Lee, S. D., 1988, 於: Journal of the Formosan Medical Association = Taiwan yi zhi. 87, 5, p. 544-548 5 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審
  2 引文 斯高帕斯（Scopus）

• Therapeutic endoscopy for dieulafoy's disease

  Lin, H. J., Lee, F. Y., Tsai, Y. T., Lee, S. D., Lee, C. H. & Kang, W. M., 10月 1989, 於: Journal of Clinical Gastroenterology. 11, 5, p. 507-510 4 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Endoscopy 100%
  • Hypertonic Glucose Solution 67%
  • Convulsive Therapy 55%
  • Hemorrhage 47%
  • Electrocoagulation 46%
  23 引文 斯高帕斯（Scopus）